Medis at CRT 2024: Review of the recent QFR Studies, principles of Medis QFR® and why we should use it by Yuhei Kobayashi, MD 

At CRT 2024, Yuhei Kobayashi, MD, will give an insightful session on the review of Medis QFR® and why you should use it. This session will take place on:

March 9, 9:41 AM – 9:49 AM ET in Lincoln

Read More

In daily clinical routine, QFR promises good diagnostic agreement as compared to both iFR and RFR.

Dr. J Stader from the University Hospital Leipzig in Germany, under the supervision of Dr. K Lenk, published this prospective, single-center study, which includes 102 patients with an indication for elective coronary angiography in the Catheterization and Cardiovascular Interventions Journal.

Read More

Influence of lesion and disease subsets on the diagnostic performance of the quantitative flow ratio in real‑world patients

Dr. J Westra and multiple co-authors, under the supervision of Dr. EH Christiansen, Dept of Cardiology, Aarhus University Hospital in Denmark, published this interesting paper in JACC Imaging.

Read More

Join Medis today at the ECR 2024 in Vienna!

Read More

Influence of lesion and disease subsets on the diagnostic performance of the quantitative flow ratio in real‑world patients

Dr. Lee KY from the Department of Cardiology, Incheon St. Mary’s Hospital, The Catholic University of Korea, and co-authors from other Korean universities published in Nature Scientific Reports a comprehensive study involving 915 patients with angina and acute myocardial infarction (AMI), where QFR demonstrated high diagnostic accuracy, exceeding 95% for identifying fractional flow ratio (FFR) ≤ 0.8 in the angina group and 92% in the AMI group.

Read More

Discover the future of STEMI management with “QFR Insights in STEMI: enhancing emergency treatment strategies” by prof. Eric van Belle

We are happy to announce that we will host another Medis QFR® Academy session, this session will feature Prof. Eric Van Belle, esteemed Head of Interventional Cardiology at University Hospital of Lille, France. He will guide us through the intricacies of using QFR in the context of ST-elevated myocardial infarction (STEMI). This session will illuminate the pivotal role of QFR in distinguishing between culprit and non-culprit lesions, using two detailed clinical case studies as a backdrop for discussion. This session will be moderated by Dr. Ignacio J Amat Santos From University of Valladolid Medical Centre in Spain.

Read More

QFR shows high correlation, diagnostic accuracy and discriminant function with FFR

In the field of coronary revascularization, where identifying reversible myocardial ischemia is paramount, FFR and iFR are standard but underutilized due to various limitations. QFR, an angiography-derived method, emerges as a potential game-changer, providing functional assessment without additional wires or hyperemic agents and showcasing a shorter measurement time than invasive methods. In conclusion, the study, aligning with ongoing trials, suggests that a QFR-guided strategy could simplify, enhance safety, and cost-effectively guide revascularization decisions. Furthermore, the findings position QFR as a promising tool to boost the adoption of physiology-based revascularization in routine clinical practice.

Read More
The latest developments of Medis QFR® – March 2024

The latest developments of Medis QFR® – March 2024

In this march edition of the Medis QFR® blog article we are proud to share five publications with you.

Read More

Robin Nijveldt

Read More
The latest developments of Medis QFR® – February 2024

The latest developments of Medis QFR® – February 2024

In this february edition of the Medis QFR® blog article we are proud to share five publications with you.

Read More